The Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Improving Care After Inherited Cancer Testing

Not Applicable

Recruiting

Conditions: Inherited Cancer Syndrome
Prostate Cancer
Endometrial Cancer
Colorectal Cancer
Breast Cancer

Interventions: Other: Correlative Studies (Survey)
Other: Correlative Studies (Interview)
Other: Access to Education Materials
Behavioral: Standard-of-care & Adaptive Intervention
Behavioral: GeneSHARE
Behavioral: LivingLabReport

First Posted Date: 2021-02-21

Last Posted Date: 2024-02-13

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 720

Registration Number: NCT04763915

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Metabolism Informed Smoking Treatment: The MIST RCT

Phase 3

Active, not recruiting

Conditions: Smoking

Interventions: Behavioral: Post-discharge automated phone calls (IVR) with option to connect with a tobacco coach.
Drug: Nicotine Replacement Therapy
Drug: Varenicline
Other: Metabolism Informed Smoking Treatment (Nicotine metabolite ratio (NMR)-based selection of pharmacotherapy)

First Posted Date: 2020-10-19

Last Posted Date: 2024-12-05

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 608

Registration Number: NCT04590404

Locations: 🇺🇸
Vanderbilt University Medical Center ViTAL, Vanderbilt Center for Tobacco, Addiction, and Lifestyle General Internal Medicine and Public Health 2525 West End Ave, Suite 450, Nashville, Tennessee, United States

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

Phase 2

Recruiting

Conditions: Soft Tissue Sarcomas

Interventions: Radiation: Ultra-Hypo-fractionation Radiotherapy
Procedure: Resection
Radiation: Moderately-Hypo-fractionation Radiotherapy
Other: Questionnaire Administration

First Posted Date: 2020-08-10

Last Posted Date: 2024-01-30

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 40

Registration Number: NCT04506008

Locations: 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor

Phase 1

Active, not recruiting

Conditions: Metaplasia
Stage I Gastric Cancer
Initial-onset Gastric Cancer
Gastric Cancer

Interventions: Drug: Trametinib treatment
Procedure: Endoscopy

First Posted Date: 2020-07-01

Last Posted Date: 2024-07-31

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 15

Registration Number: NCT04454476

Locations: 🇯🇵
Nagasaki University Hospital, Nagasaki, Japan
🇯🇵
University of Tokyo Medical Center, Tokyo, Japan
🇯🇵
Nihon University School of Medicine, Tokyo, Japan

COVID-19 and Cancer Consortium Registry

Active, not recruiting

Conditions: Invasive Malignancy (Any Type)
COVID-19

First Posted Date: 2020-04-21

Last Posted Date: 2024-01-09

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 19275

Registration Number: NCT04354701

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System

Phase 2

Terminated

Conditions: Thyroid Carcinoma
Radioactive Iodine Level

Interventions: Drug: Artificial Tears

First Posted Date: 2020-03-31

Last Posted Date: 2024-01-18

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 9

Registration Number: NCT04327999

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Impact of Human-Animal Interactions on Children With Life-Threatening Conditions and Their Parents

Not Applicable

Completed

Conditions: Refractory Cancer
Advanced Cancer
Relapsed Cancer

Interventions: Behavioral: Animal-Assisted Interactions

First Posted Date: 2020-03-17

Last Posted Date: 2024-08-19

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 74

Registration Number: NCT04310345

Locations: 🇺🇸
Monroe Carell Jr Children's Hospital at Vanderbilt, Nashville, Tennessee, United States

Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy

Not Applicable

Completed

Conditions: Parathyroid Neoplasms
Parathyroid Hyperplasia
Primary Hyperparathyroidism
Parathyroid Adenoma
Parathyroid Cancer
Hypercalcemia

Interventions: Device: NIRAF Detection Technology

First Posted Date: 2020-03-06

Last Posted Date: 2024-05-13

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 160

Registration Number: NCT04299425

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.

Not Applicable

Completed

Conditions: Thyroid Neoplasms
Postoperative Hypoparathyroidism
Thyroid Cancer

Interventions: Device: NIRAF Detection Technology

First Posted Date: 2020-02-24

Last Posted Date: 2024-10-17

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 160

Registration Number: NCT04281875

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Navigation Endoscopy to Reach Indeterminate Lung Nodules Versus Trans-Thoracic Needle Aspiration

Not Applicable

Active, not recruiting

Conditions: Lung Nodule

Interventions: Device: CT-Guided Biopsy
Device: Navigation bronchoscopy

First Posted Date: 2020-01-31

Last Posted Date: 2024-11-01

Lead Sponsor: Vanderbilt-Ingram Cancer Center

Target Recruit Count: 256

Registration Number: NCT04250194

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy